Trends in prescription and cost of Sativex, a cannabinoid-based medicine, in treating patients with multiple sclerosis in England
Sign Up to like & getrecommendations! Published in 2024 at "Journal of Pharmaceutical Policy and Practice"
DOI: 10.1080/20523211.2024.2342318
Abstract: ABSTRACT Aim: Cannabis-based medication has recently been made available in the NHS for reducing pain and spasticity in patients with multiple sclerosis (MS). The currently available preparation of Sativex (nabiximols) contains a combination of botanical… read more here.
Keywords: based sativex; cannabinoid based; medicine; patients multiple ... See more keywords